Carbon ion radiotherapy for stage I non-small cell lung cancer.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 12648784)

Published in Radiother Oncol on February 01, 2003

Authors

Tadaaki Miyamoto1, Naoyoshi Yamamoto, Hideki Nishimura, Masashi Koto, Hirohiko Tsujii, Jun-etsu Mizoe, Tadashi Kamada, Hirotoshi Kato, Shigeru Yamada, Shinroku Morita, Kyosan Yoshikawa, Susumu Kandatsu, Takehiko Fujisawa

Author Affiliations

1: Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 9-1 Anagawa, 4-chome, Inage-Ku, Chiba-shi 263-8555, Japan.

Articles citing this

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc (2008) 8.94

A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol (2012) 1.99

New challenges in high-energy particle radiobiology. Br J Radiol (2014) 1.08

Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy. Mutat Res (2011) 1.05

Radiotherapy for the future. BMJ (2005) 1.04

Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature. Front Oncol (2014) 0.94

Review of clinical experience with ion beam radiotherapy. Br J Radiol (2011) 0.91

Clinical evidence of particle beam therapy (carbon). Int J Clin Oncol (2012) 0.90

Early-stage lung cancer: diagnosis and treatment. Int J Clin Oncol (2006) 0.83

The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells. Sci Rep (2015) 0.82

The effects of carbon ion irradiation revealed by excised perforated intestines as a late morbidity for uterine cancer treatment. Surg Today (2006) 0.81

Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review. Oncologist (2010) 0.79

Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer. Lung (2006) 0.77

Carbon ion therapy for early-stage non-small-cell lung cancer. Biomed Res Int (2014) 0.76

Multigating, a 4D optimized beam tracking in scanned ion beam therapy. Technol Cancer Res Treat (2013) 0.76

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions. Front Oncol (2016) 0.76

Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial. BMC Cancer (2015) 0.75

Particle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors. Radiat Oncol (2014) 0.75

Carbon-ion pencil beam scanning for thoracic treatment - initiation report and dose metrics evaluation. J Radiat Res (2016) 0.75

Two cases of orbital adenocarcinoma treated with heavy charged carbon particle irradiation. Graefes Arch Clin Exp Ophthalmol (2005) 0.75

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer. Front Oncol (2017) 0.75

Articles by these authors

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst (2005) 13.00

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res (2005) 4.25

Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest (2004) 3.79

Particle radiation therapy using proton and heavier ion beams. J Clin Oncol (2007) 3.13

Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer (2005) 2.46

A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res (2006) 2.05

Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group. Respirology (2014) 2.05

Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol (2007) 2.03

Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest (2006) 2.00

A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol (2012) 1.99

Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2004) 1.98

Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration. Chest (2007) 1.93

A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res (2005) 1.84

Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers. Ann Surg Oncol (2006) 1.79

Early detection of COPD is important for lung cancer surveillance. Eur Respir J (2011) 1.70

Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol (2002) 1.68

Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease. Ann Thorac Surg (2003) 1.61

Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg (2007) 1.60

Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg (2006) 1.60

Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer (2005) 1.58

Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg (2006) 1.56

Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol (2004) 1.54

Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy. Lung Cancer (2004) 1.53

Fragment c gamma receptor gene polymorphisms and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat (2010) 1.53

Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors. Cancer J (2006) 1.52

Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis. Int J Radiat Oncol Biol Phys (2006) 1.49

Clinical Results of Carbon Ion Radiotherapy at NIRS. J Radiat Res (2007) 1.49

A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J Immunol (2009) 1.46

Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res (2010) 1.46

Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol (2002) 1.46

Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer (2005) 1.46

Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis? Eur J Cardiothorac Surg (2006) 1.45

Triple reconstruction of pulmonary artery, superior vena cava and bronchus for lung cancer. Interact Cardiovasc Thorac Surg (2006) 1.45

Metalloproteinase inhibition has differential effects on alloimmunity, autoimmunity, and histopathology in the transplanted lung. Transplantation (2007) 1.43

Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer (2002) 1.42

Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study. Int J Urol (2013) 1.41

Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma. Ann Thorac Surg (2004) 1.41

Indications for mediastinoscopy and comparison of lymph node dissections in candidates for lung cancer surgery. Lung Cancer (2007) 1.41

Prevalence of tuberculosis in small pulmonary nodules obtained by video-assisted thoracoscopic surgery. Respir Med (2005) 1.39

Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol (2004) 1.37

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer. Cancer (2006) 1.35

Physical performance evaluation of a 256-slice CT-scanner for four-dimensional imaging. Med Phys (2004) 1.31

Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 1.29

The structural characteristics of radiation oncology in Japan in 2003. Int J Radiat Oncol Biol Phys (2005) 1.28

High-dose proton beam therapy for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 1.28

Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys (2007) 1.27

Retracted Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene (2005) 1.25

Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res (2003) 1.23

Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol (2012) 1.22

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Int J Cancer (2005) 1.21

Somatodendritic localization of the mRNA for EFA6A, a guanine nucleotide exchange protein for ARF6, in rat hippocampus and its involvement in dendritic formation. Eur J Neurosci (2004) 1.20

Serum organochlorines and breast cancer risk in Japanese women: a case-control study. Cancer Causes Control (2008) 1.20

Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol (2003) 1.19

Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma. Ann Thorac Surg (2007) 1.18

Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg (2003) 1.18

Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation (2002) 1.17

Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res (2006) 1.16

Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.16

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother (2004) 1.15

Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk. Cancer (2012) 1.15

Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys (2004) 1.14